CHICAGO, IL—RBT-1, a novel pharmacologic approach to preconditioning, appeared beneficial in patients undergoing CABG and/or valve surgery in an interim analysis of the phase II START trial. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results